Yes. PMOS (polyendocrine metabolic ovarian syndrome) is simply the new name for PCOS (polycystic ovary syndrome). The condition itself has not changed.

The name was changed in May 2026 by a global consensus published in The Lancet, because “polycystic” was inaccurate — the condition does not involve true ovarian cysts. What a scan shows are arrested follicles, not cysts. The old name also made it sound purely gynaecological, when it actually affects hormones, metabolism, skin, fertility and mental health.

Your diagnosis, your tests and your treatment stay exactly the same. Both names will appear in medical records and lab reports for some time.

Because PMOS is driven largely by insulin resistance, which actively works against weight loss.

When your cells respond poorly to insulin, your body produces more of it. High insulin promotes fat storage, increases hunger, and pushes the ovaries to produce more androgens — which in turn worsens insulin resistance. It becomes a loop. This is why women with PMOS often find that the same diet and exercise that works for a friend does very little for them.

It is not a lack of willpower. It is a metabolic headwind, and it usually needs to be addressed metabolically.

Losing around 5–10% of your body weight is enough to make a meaningful difference for many women.

At that level, insulin levels fall, androgen levels drop, and ovulation and menstrual cycles often become more regular. For a woman weighing 75 kg, that is roughly 4–8 kg — far less than most people expect.

This is the figure recommended in the 2023 International Evidence-based Guideline for PCOS. It will not work for everyone, and it is not a cure, but it is the single most effective first step for most women carrying excess weight.

They can help with the weight and insulin resistance that drive PMOS — but it is important to be precise about what they are approved for.

In India, GLP-1 medicines such as tirzepatide (Mounjaro) and semaglutide (Wegovy) are approved for weight management in people with obesity, and for type 2 diabetes — not specifically for PMOS. However, because they improve insulin sensitivity and produce substantial weight loss, many women with PMOS and obesity see their cycles, androgen levels and metabolic markers improve as a result.

Whether they are appropriate for you depends on your BMI, your other health conditions, and whether you are trying to conceive. This is a decision for a doctor, not a website.

Indian guidance uses lower BMI cut-offs than Western guidelines, because South Asians carry more visceral fat and develop metabolic disease at a lower weight.

The 2025 ESI obesity guidelines for India suggest anti-obesity medication, including GLP-1 receptor agonists, is considered after a structured lifestyle intervention at a BMI of about 27 or above, or from a BMI of 25 if you have a related condition — such as type 2 diabetes, prediabetes, high blood pressure, abnormal cholesterol, fatty liver, or sleep apnoea. PMOS with insulin resistance is commonly part of that picture.

They do different jobs, and the right answer depends on your goal.

Metformin has been used in PCOS for decades. It improves insulin sensitivity, is inexpensive, and is well understood — but it produces only modest weight loss, typically 2–3 kg.

GLP-1 medicines produce far greater weight loss, which is often what actually shifts PMOS symptoms. They are more expensive and are injectables.

Some women are prescribed one, some the other, and some both. If you are actively trying to conceive, the calculus changes again — GLP-1 medicines are stopped before pregnancy. A doctor needs to weigh this up with you.

Yes — PMOS significantly raises your risk of type 2 diabetes, and Indian women face that risk earlier and at a lower BMI.

Because insulin resistance sits at the core of the condition, the pancreas has to work harder for years to keep blood sugar normal. Over time it can struggle to keep up. Studies suggest a substantial proportion of women with the condition develop prediabetes or type 2 diabetes by their forties.

The practical takeaway: if you have PMOS, ask your doctor to check your blood sugar (HbA1c or a glucose tolerance test) and your lipids, even if you feel well.

Yes. PMOS is a leading cause of difficulty conceiving, but most women with the condition can and do get pregnant — often with treatment, and sometimes without.

The core problem is irregular or absent ovulation. Because weight loss can restore ovulation, it is frequently the first thing recommended. Beyond that, ovulation-induction medicines are highly effective, and IVF is available where needed.

Important: GLP-1 medicines are not used during pregnancy and must be stopped well before trying to conceive. If pregnancy is your goal, say so at your first consultation — it changes the entire treatment plan.

There is no single “PCOS diet” — but the principle that matters most is controlling the insulin response, which means paying attention to carbohydrate quality and protein intake.

Practically, for an Indian diet: reduce refined carbohydrates (white rice, maida, sugar, biscuits, sweets), favour whole grains, millets and pulses, and make sure every meal has a real protein source — dal, paneer, curd, eggs, chicken, fish, soya. Adequate protein also protects muscle while you lose fat.

Crash dieting tends to backfire. Consistency beats severity.

It often helps, but it is slower than weight loss itself, and it is rarely a complete fix on its own.

Excess facial hair, jawline acne, and scalp hair thinning are all driven by raised androgens. Weight loss lowers insulin, which lowers androgen production — so these symptoms tend to improve. But hair follicles respond slowly: expect months, not weeks, and existing coarse hair will not disappear by itself.

Many women get the best result by combining weight management with treatments aimed directly at the skin and hair. Discuss this with a doctor rather than treating it as a cosmetic problem alone.

Diagnosis follows the Rotterdam criteria: you need two of three features — irregular or absent ovulation, signs of raised androgens (clinical or on a blood test), and polycystic ovarian morphology on ultrasound.

In practice a doctor will typically take a history of your cycles, examine you, and order blood tests — testosterone and other androgens, LH/FSH, AMH, thyroid function and prolactin (to rule out mimics), plus blood sugar and lipids to assess metabolic risk. A pelvic ultrasound may be added, though it is not always required.

No online quiz, including ours, can replace this.

The most common side effects are gastrointestinal: nausea, vomiting, constipation, diarrhoea, and reflux. They are usually worst in the first weeks and after each dose increase, and they typically settle.

This is exactly why the dose is started low and raised slowly, and why medical supervision matters. Rarer but more serious risks — including pancreatitis and gallbladder problems — need to be discussed with a doctor, along with your personal and family medical history.

These are prescription medicines in India, and they should never be bought or self-administered without a doctor.

Most people notice reduced appetite within the first weeks, but meaningful weight loss builds over months, not days.

Treatment starts at a low dose and steps up gradually to let your body adjust and to limit side effects. Weight loss typically continues over the course of a year. Reviews of the clinical evidence show substantial average weight loss over roughly 12–16 months of treatment.

Expecting rapid results in the first month is the most common reason people give up too early.

Often, yes — unless the underlying habits and metabolic drivers have been addressed.

Obesity is a chronic, relapsing condition. GLP-1 medicines work while they are being taken; when they stop, appetite signals return, and studies show a significant proportion of lost weight is regained over the following year.

This is why medication alone is a weak strategy. Pairing it with nutrition, resistance training to protect muscle, and a plan for what happens after treatment is what makes the result durable. That is the whole reason Karespot combines medication with coaching rather than simply dispensing a prescription.